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Abstract. Patients who undergo mechanical heart valve replacements
or have conditions like Atrial Fibrillation have to take Vitamin K Antag-
onists (VKA) drugs to prevent coagulation of blood. These drugs have
narrow therapeutic range and need to be very closely monitored due to
life threatening side effects. The dosage of VKA drug is determined and
revised by a physician based on Prothrombin Time - International Nor-
malised Ratio (PT-INR) value obtained through a blood test. Our work
aimed at predicting the maintenance dosage of warfarin, the present most
widely recommended anticoagulant drug, using the de-identified medical
data collected from 109 patients from Kerala. A Support Vector Machine
(SVM) Regression model was built to predict the maintenance dosage
of warfarin, for patients who have been undergoing treatment from a
physician and have reached stable INR values between 2.0 and 4.0.
Keywords: Cardiac Valve Replacement - Mechanical Heart Valve -
Atrial Fibrillation - Vitamin K Antagonists (VKA) - Prothrombin Time
- International Normalised Ratio (PT-INR) - Warfarin - Support Vector
Machine (SVM) Regression - Algorithm - Artificial intelligence - Machine
Learning.
1 Introduction
Patients who undergo cardiac procedures such as mechanical heart valve replace-
ment and those who have atrial fibrillation require oral anticoagulant (OAC)
? The current work is the result of a Memorandum of Understanding between Na-
tional Institute of Technology Calicut and Sree Chitra Tirunal Institute for Medical
Sciences and Technology, Thiruvananthapuram
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drugs, mostly Vitamin K antagonists (VKA) to prevent blood clotting. The
dosage of VKA drugs are monitored by physicians by observing PT-INR (Pro-
thrombin Time International Normalised Ratio) values obtained through a
blood test. These VKA drugs have got a very narrow therapeutic range[1], so
they require very close monitoring. This will normally require the services of a
physician.
Developing countries like India have disparities in access to healthcare where
the patients find it difficult to get the services of a physician. Patients have to
travel long distances to meet a physician to show the results of PT-INR and
alter the dosage of the drugs, if necessary. The cost of travelling and physical
disabilities, which prevent patients from travelling, make recurrent blood tests a
tedious process. This forces the patient to avoid doing the test, which can lead
to bleeding or formation of blood clots inside blood vessels (thrombosis).
Of late, the PT-INR test is widely available in many small laboratories even in
villages and also as point-of-care (POC) devices, which are readily available and
can be used at home. If we can predict the warfarin dosage from PT-INR results
using a handheld device like a mobile phone or a computer based application, it
will be useful to people with limited healthcare access.
Identifying a stable dose of warfarin just after initiation of the drug is a
tedious process which requires supervision of a physician and is usually done
before the patient is discharged, for example after the valve surgery [1]. Our work
focuses on predicting the maintenance dosage in patients who are on follow-up
at home with stable INR readings for some time.
Studies in the field have shown that, incorporating pharmacogenomic data
can lead to higher accuracy compared to clinical models in warfarin dosage
prediction [2]. But the genetic information used in the pharmacogenetic models
is difficult to obtain and the gene variant with biggest influence on prediction
varies between populations [3]. So we thought of developing a simple algorithm
based on previous and current INR values and the last drug dose, as required
for the different indications.
This paper is organized as follows. The next section, Section 2 discusses about
existing literature on clinical and pharmacogenetic warfarin dosage prediction.
Details of preliminary analysis of dataset used for the work is provided in Sec-
tion 3. Section 4 discusses different machine learning models that were tried out.
Section 5 describes the algorithm used to convert predicted daily dosage (in dec-
imals) to weekly dosage sequence (in integer) to match current clinical practice.
Section 6 is about the client application designed to be used by patients and
doctors for dosage prediction.
2 Literature Survey on Methods of Warfarin Prediction
As mentioned in the introduction, finding the required dosage of VKAs for a
particular patient begins just after surgery while he/she is in the hospital. The
patient is discharged on this particular dose. Then the patient checks PT-INR
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periodically and adjusts the dose initially every week for one month, then fort-
nightly for two months and then monthly thereafter.
There were many attempts using machine learning to predict the VKA dose
requirement. Sharabiani et al [4] developed a methodology to predict the initial
dosage of warfarin for new patients. The patients were classified into 2 groups,
those who require more than 30mg of warfarin per week and those requiring
less than 30mg per week. The classification was done using Relevance Vector
Machines (RVM). For each class, customised regression models were developed
to predict the dosage for each patient in the respective class. The dataset used
in this approach was multi-ethnic and contained continuous variables like body
surface area (BSA) and PT-INR along with categorical variables such as gender,
race, presence of diabetes , and history of smoking with the most weightage given
to the BSA. The prediction accuracy was 11.6 in terms of root mean squared
error (RMSE). This accuracy is insufficient to be practically used. One reason for
high error rate is the high dependency of warfarin on the demographic data[5].
Hence, using a multi-ethnic dataset to train the model could result in lower
accuracy.
Another study by Schelleman et al [3], aimed to develop a dosage prediction
algorithm for Caucasians and African Americans by taking into account the
clinical, environmental and genetic factors and comparing the result obtained
with giving the empirical 5mg per day as maintenance dosage. The dataset
considered variables like age, gender, body surface area and had information
about the variants in CYP2C9 and VKORC1 genes which are responsible for
the metabolism and action of the VKA drugs. Separate models were built for
Caucasians and African Americans. In both the models, highest weightage was
given to the VKORC1 gene variant variable. The model for Caucasians obtained
better accuracy than the model for African Americans. The reason for this, they
claimed, might be because they had not considered certain gene variants which
might have been more important than the VKORC1 gene variant. Since the
model focused primarily on Caucasians and African Americans, the same model
may not be applicable to Indian population and we do not have genetic data
from all our population.
The members of the International Warfarin Pharmacogenetics Consortium
(IWPC) developed a pharmacogenetic prediction model [2] to predict a stable
therapeutic dose of warfarin and compared the result with that of a model which
only considered the clinical factors and a model which gave fixed dosage to indi-
viduals. The dataset considered contained data of individuals from 9 countries
and 4 continents whose target INR was between 2 and 3. Genotypic variables
were taken into account along with the variables like age, race, height, etc. The
model with the least predictive mean absolute error was chosen as the best model
for all the three cases considered. They are
1. Taking into account the pharmacogenetic factors,
2. Taking into account only the clinical factors, and
3. Model which gave a fixed dose of 5mg of warfarin per day.
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The performance of the algorithms was checked in three dose groups, those
with less than 21 mg per week, those who require more than 49mg per week and
those who require doses between 21 mg and 49 mg per week. The least squares
linear regression modelling method was used to develop the required algorithm
which gave the square root of the required dose. The result of this model claimed
that the model taking into account the pharmacogenetic factors predicted the
dosage with maximum accuracy. Then came the model which took into account
the clinical factors.
It was observed that in most of the cases, the physician predicts the dosage
without considering the patients genotypic data, which is not usually available.
The genetic factors influenced more in the initial dosage prediction, than the
prediction of the maintenance dose.
Considering the above discussed factors, there is a need for a better, more
localised approach in developing the required algorithm. There are no predictive
algorithms specific to Indian patients . We attempted to develop an algorithm
using de-identified patient data obtained from Sree Chitra Tirunal Institute for
Medical Sciences and Technology (SCTIMST).
3 Data Collection, Analysis and Preprocessing
3.1 Dataset Collection
This project is done in collaboration with National Institute of Technology Cali-
cut (NITC) and SCTIMST. SCTIMST provided the deidentified data of 109
Indian patients who are attending the INR Clinic of SCTIMST, to NITC. The
data model parameters are described in Table 1.
Table 1: Data Parameters description
S.No Parameter Description
1 Age Age of the patient
2 Old INR Value INR value of patient before PT-INR test
3 New INR Value INR value of patient after PT-INR test
4 Old Dosage Old warfarin dosage of the patient (in mg)
5 Gender Gender of the patient
6 Procedure type Type of procedure the patient had under-
gone. It can be MVR, DVR, AVR or AF.
7 New Dosage New warfarin dosage prescribed by the
doctor after the INR test (in mg)
MVR - Mitral Valve Replacement, AVR - Aortic Valve Replacement, DVR - Double
Valve Replacement, AF - Atrial Fibrillation, INR - International Normalised Ratio
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3.2 Dataset Analysis
A preliminary analysis was conducted on the dataset to figure out patterns and
possible biases in the data. Frequency distribution of parameters are plotted to
figure out shortcomings in dataset. The plots are given from Figure 1 to Figure
5.
Gender Distribution The dataset has adequate representation from male and
female population. Data points from other genders are absent, which may lead
to inaccurate results for LGBTQ patients. See Figure 1.
Procedure Type Distribution Patients undergoing AVR and MVR proce-
dures are represented well. A shortage of data from AF and DVR categories can
be seen in Figure 2.
Fig. 1: Gender distribution Fig. 2: Procedure type distribution
Age Distribution Patients from age 12 to 94 are present in the dataset. Pa-
tients in age group 40 to 70 are generally well represented. See Figure 3.
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Fig. 3: Age distribution Fig. 4: Old INR distribution
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Old INR value Distribution Adequate data points are present in the dataset
with old INR values ranging from 1.7 to 5.5. See Figure 4.
New INR Value Distribtion Sufficient data points are present in the dataset
with new INR values in target range 1.6 to 5.5. See Figure 5.
Fig. 5: New INR distribution
3.3 Data Preprocessing
Data preprocessing is done to improve the accuracy of the model. The dataset
has old dosage and new dosage given as daily dosage for some patients and as
dosage sequence for other patients. The dosage sequence varies from fixed single
daily dose to sequential dosing (two-day sequence to four-day sequence eg. 2 mg,
3 mg, 3 mg and this cycle repeats every third day). In order to attain uniformity
in dataset, the sequence is averaged out to daily dosage by dividing the sum of
sequence by the number of days.
Some patient data also contains dosage of acenocoumarol (acitrom), another
commonly used VKA oral drug. Warfarin dosage is converted to acitrom dosage
by dividing by a factor of two based on clinical data [6].
The categorical parameters present in the dataset (Gender and Procedure
type) are encoded using one-hot encoding scheme. One hot encoding scheme
encodes categorical parameters using binary representation to remove any extra
weight assigned to higher integer value of categorical label in the schema [7].
Gender is encoded with two binary variables and procedure type is encoded
with four binary variables.
4 Machine Learning Models
A general procedure of randomly splitting dataset into 70% training data and
30% testing data was followed and a set of machine learning models was applied
8 Amruthlal M et al.
to detect accuracy.
The accuracy of regression models was compared using R square value.
R2 = (1− u/v)
where,
u =
dataset−size∑
n=1
(y(n)true − y(n)predicted)2
v =
dataset−size∑
n=1
(y(n)true − ymean)2
y(n)true = Real warfarin dosage of n
th patient
y(n)predicted = Predicted warfarin dosage of n
th patient
ymean = Mean real warfarin dosage
The best possible value for R is 1.0.
4.1 Linear Regression (LR) model
In statistics, linear regression is a modelling tool used for mapping the rela-
tionship between a scalar response and one or more explanatory variables. The
regression coefficients obtained in linear regression training is given in Table 2.
Table 2: Regression coefficients of LR Model
Feature Coefficient
Gender .268093776
Procedure type -.0392217685
Age .000704527364
Old INR .164906416
New INR -.777297970
Old Dose .917862769
Observations A variance score of 0.951 and mean square error of 0.439 was
observed which strongly suggests that data is linearly distributed. The highest
coefficient was obtained for old dosage and new INR suggesting that the target
new dosage is more co-related to these parameters.
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4.2 Support Vector Regression (SVR) Model
Support Vector Machines are models which are trained under the condition that
an optimal hyperplane exists which separates the dataset into different classes
[8]. It can be represented as the equation given below.
f(x) = wx+ b (1)
Where f(x) is the optimal hyperplane with normal vector w and intercept b.
Support vector regressions adds an extra condition that f(x) should satisfy
|f(x)− y(x)|<e (2)
where y(x) is the labelled value function and e is the error tolerance.
Kernels used Kernels can be used to map the dataset to different dimensions
to obtain more seperability. The kernels tested include
1. Linear kernel with e = 0.01
2. Polynomial kernel with degree = 2 and e = 0.01
3. Radial Basis Function kernel with gamma = 0.1 and e = 0.01
The optimal e value for training was found to be 0.01 through k fold cross vali-
dation. The dataset was split into 10 groups (k = 10) in random and one group
is chosen as the testing set and the rest as training set. Training is conducted
with e values 0.001, 0.01, 0.1, 1.0, 10 and it is found that e = 0.01 gives better
average variance.
Table 3: Coefficients of Linear SVMR Model
Feature Coefficient
Sex 0.95736124
Procedure -0.00674263
Age 0.13047947
Old INR 1.36002697
New INR -3.26086646
Old Dose 0.955252
Observations It is found that linear kernel model gives the lowest mean square
error value of 0.41 and variance value of 0.955. The coefficients of linear SVR
are given in Table 3
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5 Weekly Dosage Prediction Algorithm
The predicted daily dosage of warfarin has nanogram precision whereas the war-
farin medicine is available only in doses of milligrams. Hence, an algorithm was
designed to convert the daily decimal dosage (in mg) to a weekly sequence of
integers. The algorithm takes predicted daily dosage and sequence length to pro-
duce best possible sequence with given sequence length and minimal error from
predicted daily dosage.
1. Initialize lower-bound = floor(daily dosage)
2. Initialize upper-bound = ceil(daily dosage)
3. Initialize predicted-sequence = {lower-bound} with length sequence-length
4. Initialize target-sum = predicted-dosage*sequence-length
5. while(sum(predicted-sequence) - target-sum <= 0) do
– previous-sequence = predicted-sequence
– replace last found occurrence of lower-bound with upper-bound in predicted-
sequence
6. Return minimum of previous sequence, predicted-sequence with respect to
the minimization function abs(sum(sequence) - target-sum)
6 Client Application
The application was developed in the Android Platform. Since the app is going
to be used by the common man, care was taken to make it simple and user
friendly. Initially, when the mobile application is loaded, the user has to authen-
ticate with username and password. This will guide them to the main page. This
main page will have fields namely patient’s age, gender, old INR value, new INR
value and old dosage, which the user has to enter. The initial entry is to be done
by hospital staff and the patient needs to enter only the old INR value, new INR
value and old dosage. The old dosage can be entered as a single value or a set of
values. When the user clicks the Predict button, if the values entered by the user
are all valid, the user is directed to the output page which shows the warfarin
dosage of the patient for the next week.
The initial version of the application was tested in the heart failure clinic
of SCTIMST and based on the feedback, many modifications were done in the
application. The window to enter three consecutive day doses and the provision
the enter the drug acenocoumarol (acitrom) were added. The conversion from
acitrom to warfarin is by mutiplying with a factor of 2 as the drug is more potent.
The current version of the app, displays the drug doses for a week starting from
the date of entry not in descending order as before (eg 3mg, 3mg, 2mg, 2mg,
2mg, 2mg, 2mg) but varying doses interspersed(eg 2mg, 3mg, 2 mg, 3mg, 2mg,
2mg, 2mg)
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Fig. 6: Login Screen Fig. 7: Input Screen Fig. 8: Output Screen
7 Results
Various machine learning models are compared and linear SVM Regression
model with coefficients given in Table 3 gave the best variance score and ac-
curacy. Regression models with linear base generally outperforms other models
in prediction. It is found out that new INR value and old dosage are the prin-
cipal components in prediction of new dosage. The daily dosage predicted by
the server is stable and usable in case of stable INR value range of two to four.
For an INR value below 2 and above 4, it was decided to refer for the help of a
physician as he/she may need urgent medical help. The weekly prediction model
also provides reasonable accuracy with one-off errors in boundary cases. Weekly
model is going to be tested in the INR clinic of SCTIMST for further improve-
ment in accuracy. A variance score of 0.955 was obtained for daily prediction
with mean square error of 0.41.
8 Pre testing the clinical accuracy of the application
The application was pretested using a different set of 50 physician assigned
values for INR prediction in the INR Clinic of SCTIMST. It was found that the
application predicted the values accurately in lower INR ranges, but towards
the higher range(3.5-4 range of INR), there was variation compared to physician
assigned values in the tune of upto 5 mg in weekly doses. This indicates the need
for further refinement of the algorithm, probably by re-training the algorithm
with more physician derived datasets. We are planning to use 500 more data to
try and improve the accuracy of the algorithm.
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9 Future Research - Clinical testing of the Algorithm in
patients
Once we improve the accuracy as described above and find the values in the
acceptable range compared to physician derived values, we will approach the
ethics committee of SCTIMST to test the efficacy and utility of this application
in patients attending the INR clinic of SCTIMST. Once the efficacy and utility
is proven it will be released to the public.
10 Conclusion
A warfarin dosage prediction algorithm was developed using data from Indian
patients. The linear regression model and the support vector regression model
were tested and the support vector regression model was found to show better
results with a lowest mean square error value of 0.41 and a variance value of
0.955. A mobile application was developed using the algorithm and is going to
be tested in the INR clinic of SCTIMST in a larger group of patients for ease
of use and accuracy. The application, after testing, can be used for prediction
of daily and weekly dosage of warfarin and acenocoumarol for patients without
consulting a physician. Patients who are on the above oral anticoagulants from
remote areas can use this application installed in their mobile phones.
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